Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic Nineties and beach-body-ready Noughties, the judgement is real. It is ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

A once-weekly injection for weight loss known as a ‘GP-1 agonist’. It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood. Developed originally for diabetes but ...

Rosie Green gets the lowdown on the common causes - and the best treatments - from leading dermatologist Dr Stefanie Williams.

From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...

As obesity becomes an increasingly common health concern in India, many individuals are turning to bariatric surgery and weight loss injections to manage their weight and improve overall well-being.